Vcanbio Cell & Gene Engineering Corp Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Vcanbio Cell & Gene Engineering Corp Ltd cash flow conversion efficiency. Based on the latest financial reports, Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥103.70 Million ≈ $15.17 Million USD) by net assets (CN¥3.76 Billion ≈ $550.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Vcanbio Cell & Gene Engineering Corp Ltd (1998–2025)

Cash flow conversion efficiency of Vcanbio Cell & Gene Engineering Corp Ltd from 1998 to 2025. This chart illustrates how Vcanbio Cell & Gene Engineering Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600645 share price today for real-time trading data and today's change.

Vcanbio Cell & Gene Engineering Corp Ltd Cash Flow Conversion Ratio Explained

Vcanbio Cell & Gene Engineering Corp Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Vcanbio Cell & Gene Engineering Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vcanbio Cell & Gene Engineering Corp Ltd ranked by their cash flow conversion efficiency. Also see Vcanbio Cell & Gene Engineering Corp Ltd stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Zhejiang Shibao Co Ltd SHE:002703	0.046x
Sarawak Oil Palms Bhd KLSE:5126	0.029x
Shandong Sacred Sun Power Sources Co Ltd SHE:002580	0.017x
Asuransi Jiwa Sinarmas Msig PT JK:LIFE	0.023x
NAVIGATOR HLDGS LTD F:1NV	0.039x
Supreme Electronics Co Ltd TW:8112	-0.817x
PT Sarana Menara JK:TOWR	0.152x
VIEL & Cie société anonyme PA:VIL	0.110x

Annual Cash Flow Conversion Efficiency for Vcanbio Cell & Gene Engineering Corp Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Vcanbio Cell & Gene Engineering Corp Ltd from 1998 to 2025. Review free cash flow generation of Vcanbio Cell & Gene Engineering Corp Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.75 Billion ≈ $549.45 Million	CN¥313.63 Million ≈ $45.89 Million	0.084x	+7.17%
2024-12-31	CN¥3.66 Billion ≈ $535.44 Million	CN¥285.19 Million ≈ $41.73 Million	0.078x	-0.99%
2023-12-31	CN¥3.80 Billion ≈ $555.86 Million	CN¥299.02 Million ≈ $43.76 Million	0.079x	+9.82%
2022-12-31	CN¥3.65 Billion ≈ $534.64 Million	CN¥261.89 Million ≈ $38.32 Million	0.072x	-21.10%
2021-12-31	CN¥3.53 Billion ≈ $516.95 Million	CN¥320.96 Million ≈ $46.97 Million	0.091x	+30.22%
2020-12-31	CN¥3.50 Billion ≈ $512.51 Million	CN¥244.35 Million ≈ $35.76 Million	0.070x	-0.02%
2019-12-31	CN¥3.46 Billion ≈ $506.41 Million	CN¥241.49 Million ≈ $35.34 Million	0.070x	+60.09%
2018-12-31	CN¥2.98 Billion ≈ $436.71 Million	CN¥130.08 Million ≈ $19.04 Million	0.044x	+1.38%
2017-12-31	CN¥1.63 Billion ≈ $239.17 Million	CN¥70.27 Million ≈ $10.28 Million	0.043x	-47.58%
2016-12-31	CN¥1.75 Billion ≈ $256.34 Million	CN¥143.67 Million ≈ $21.02 Million	0.082x	+1587.16%
2015-12-31	CN¥1.68 Billion ≈ $246.10 Million	CN¥8.17 Million ≈ $1.20 Million	0.005x	-97.46%
2014-12-31	CN¥1.16 Billion ≈ $169.20 Million	CN¥221.45 Million ≈ $32.41 Million	0.192x	+14.17%
2013-12-31	CN¥660.07 Million ≈ $96.59 Million	CN¥110.72 Million ≈ $16.20 Million	0.168x	-32.93%
2012-12-31	CN¥281.54 Million ≈ $41.20 Million	CN¥70.41 Million ≈ $10.30 Million	0.250x	-39.12%
2011-12-31	CN¥268.85 Million ≈ $39.34 Million	CN¥110.44 Million ≈ $16.16 Million	0.411x	-42.99%
2010-12-31	CN¥244.13 Million ≈ $35.72 Million	CN¥175.93 Million ≈ $25.74 Million	0.721x	+38.01%
2009-12-31	CN¥239.23 Million ≈ $35.01 Million	CN¥124.92 Million ≈ $18.28 Million	0.522x	+10.06%
2008-12-31	CN¥256.31 Million ≈ $37.51 Million	CN¥121.60 Million ≈ $17.79 Million	0.474x	-21.23%
2007-12-31	CN¥185.42 Million ≈ $27.13 Million	CN¥111.68 Million ≈ $16.34 Million	0.602x	+45.63%
2006-12-31	CN¥184.04 Million ≈ $26.93 Million	CN¥76.12 Million ≈ $11.14 Million	0.414x	-19.44%
2005-12-31	CN¥164.95 Million ≈ $24.14 Million	CN¥84.69 Million ≈ $12.39 Million	0.513x	+175.49%
2004-12-31	CN¥309.95 Million ≈ $45.36 Million	CN¥57.76 Million ≈ $8.45 Million	0.186x	+62.98%
2003-12-31	CN¥365.02 Million ≈ $53.41 Million	CN¥41.74 Million ≈ $6.11 Million	0.114x	+377.40%
2002-12-31	CN¥357.83 Million ≈ $52.36 Million	CN¥-14.75 Million ≈ $-2.16 Million	-0.041x	+75.21%
2001-12-31	CN¥414.06 Million ≈ $60.59 Million	CN¥-68.84 Million ≈ $-10.07 Million	-0.166x	-327.53%
2000-12-31	CN¥433.95 Million ≈ $63.50 Million	CN¥31.71 Million ≈ $4.64 Million	0.073x	+632.86%
1999-12-31	CN¥414.12 Million ≈ $60.60 Million	CN¥4.13 Million ≈ $604.18K	0.010x	+112.92%
1998-12-31	CN¥416.47 Million ≈ $60.94 Million	CN¥-32.14 Million ≈ $-4.70 Million	-0.077x	--

About Vcanbio Cell & Gene Engineering Corp Ltd

SHG:600645 China Biotechnology

Market Cap

$1.20 Billion

CN¥8.21 Billion CNY

Market Cap Rank

#7853 Global

#1732 in China

Share Price

CN¥17.55

Change (1 day)

-1.74%

52-Week Range

CN¥16.74 - CN¥32.94

All Time High

CN¥68.93